Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

EQUITY (Narrative) (Details)

v3.25.1
EQUITY (Narrative) (Details)
$ / shares in Units, $ / shares in Units, ₪ in Thousands, $ in Thousands
 1 Months Ended 12 Months Ended
Nov. 12, 2024
CAD ($)
shares
Nov. 12, 2024
USD ($)
$ / shares
May 08, 2023
CAD ($)
shares
May 08, 2023
USD ($)
$ / shares
Mar. 14, 2022
CAD ($)
$ / shares
shares
Mar. 14, 2022
ILS (₪)
Oct. 31, 2024
CAD ($)
Shares
$ / shares
shares
Feb. 28, 2023
CAD ($)
shares
Feb. 28, 2023
USD ($)
$ / shares
shares
Aug. 19, 2022
CAD ($)
shares
Aug. 19, 2022
USD ($)
shares
Mar. 28, 2022
CAD ($)
$ / shares
shares
Mar. 28, 2022
ILS (₪)
Dec. 31, 2024
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2023
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2023
USD ($)
Shares
shares
Dec. 31, 2022
CAD ($)
Shares
$ / shares
shares
Nov. 12, 2024
$ / shares
Oct. 31, 2024
$ / shares
May 08, 2023
USD ($)
$ / shares
shares
Feb. 28, 2023
USD ($)
$ / shares
shares
Oct. 31, 2022
CAD ($)
Oct. 31, 2022
USD ($)
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Number of shares issued | shares                           3,085,452 2,232,359                
Proceeds from issuing shares                           $ 944,000 $ 1,688,000   $ 3,756,000            
Common shares issued as debts settlement with related parties | shares                           0 82,082 82,082 0            
Gross proceeds from warrants recorded as Share capital and premium                           $ 1,154,000 $ 7,253,000                
Number of warrants exercised | Shares                             9,167,000 9,167,000 0            
Weighted average value of each option grant | $ / shares                           $ 3 $ 6.6   $ 65.1            
Number of share options exercised | Shares                                 3,784            
Exercise price of compensation option | $ / shares                                 $ 96            
Number of share options granted | Shares                           31,305 500 500 5,417            
Share-based compensation                           $ 369,000 $ 225,000   $ 2,637,000            
Number of compensation warrants to acquired | shares                           14                  
Repayments of borrowings, classified as financing activities                           $ 3,834,000 4,827,000   $ 4,976,000            
Borrowings                           $ 15,611,000 $ 12,513,000                
Common Shares issued as a result of options exercises | shares                           0 0 0 3,622            
Value of shares issued options exercises                                 $ 333,000            
Common shares issued upon RSUs vested | shares                           0 9,167 9,167 0            
L5 Capital [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Number of shares issued | shares     82,082                                 82,082      
Par value per share | $ / shares                                       $ 7      
Exercise price of warrants issued per common share | $ / shares       $ 9                                      
Term of warrants     36 months 36 months                                      
Repayments of borrowings, classified as financing activities     $ 839,000 $ 616                                      
Private Placements [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Number of shares issued | shares                   100,000 100,000                        
Proceeds from issuing shares                             $ 3,756,000 $ 3,000              
Transaction costs incurred for common share issuance                   $ 178,000                          
Gross proceeds from issuance of units                   $ 6,500,000 $ 5,000                        
Pharm Yarok [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Number of shares issued | shares         8,728                                    
Par value per share | $ / shares         $ 156.96                                    
Proceeds from issuing shares         $ 1,370,000                                    
Vironna pharmacy [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Number of shares issued | shares         8,089                                    
Par value per share | $ / shares         $ 134.88                                    
Proceeds from issuing shares         $ 1,091,000 ₪ 3,500                                  
Oranim Pharm [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Number of shares issued | shares                       4,184                      
Par value per share | $ / shares                       $ 150.6                      
Proceeds from issuing shares                       $ 600,000 ₪ 1,500                    
Life Offering [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Number of shares issued | shares               471,375                         471,375    
Par value per share | $ / shares                                         $ 7.5    
Proceeds from issuing shares               $ 4,705,000 $ 3,535                            
Exercise price of warrants issued per common share | $ / shares                 $ 9                            
Term of warrants               36 months 36 months                            
Direct and incremental transaction costs               $ 334,000                              
Concurrent Offering [Member] | Non-brokered private placement [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Number of shares issued | shares               386,195                         386,195    
Par value per share | $ / shares                                         $ 7.5    
Proceeds from issuing shares               $ 3,854,000 $ 2,896                            
Exercise price of warrants issued per common share | $ / shares                 $ 9                            
Term of warrants               36 months 36 months                            
Total concurrent offering units | shares               193,333 193,333                            
January February 2023 Warrants [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Derivative liability               $ 7,027,000                         $ 5,277    
Transaction costs incurred for common share issuance               268,000                              
January February 2023 Warrants [Member] | Share Capital [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Gross proceeds from warrants recorded as Share capital and premium               1,754,000 $ 1,319                            
Transaction costs incurred for common share issuance               $ 66,000                              
May 2023 Warrants [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Derivative liability     226,000                                 $ 166      
May 2023 Warrants [Member] | Share Capital [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Gross proceeds from warrants recorded as Share capital and premium     $ 613,000 $ 450                                      
November 2024 Warrants [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Transaction costs incurred for common share issuance $ 1,154,000                                            
Direct and incremental transaction costs 49,000                                            
Recorded as deduction from share capital and premium $ 40,000                                            
November 2024 Warrants [Member] | Non-brokered private placement [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Number of shares issued | shares 742,517                                            
Par value per share | $ / shares                                   $ 2.88          
Proceeds from issuing shares   $ 2,138                                          
Exercise price of warrants issued per common share | $ / shares   $ 4.32                                          
Direct and incremental transaction costs $ 89,000                                            
November 2024 Warrants [Member] | Share Capital [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Transaction costs incurred for common share issuance $ 984,000                                            
Pre Funded Warrants [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Fair value of warrants                           $ 496,000                  
(Gain) loss on revaluation                           $ 56,000                  
Various Institutions [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Borrowings                                           $ 10,832,000 $ 8,000
Non-Independent Director [Member] | Life Offering [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Exercise price of warrants issued per common share | $ / shares                 $ 9                            
Term of warrants               36 months 36 months                            
Number Of Shared Subscribed | shares               21,950 21,950                            
Value Of Shared Subscribed               $ 222,000 $ 165                            
Guarantor (Chairman & CEO) [Member] | Pre Funded Warrants [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Par value per share | $ / shares                                     $ 2.88        
Common shares issued as debts settlement with related parties | shares             110,576                                
Number of warrants issued for common shares | Shares             152,701,000                                
Exercise price of warrants issued per common share | $ / shares             $ 0.00001                                
Derivative liability             $ 440,000                                
Amount of common shares recognized as part of permanent equity             $ 318,000                                
Guarantor (Chairman & CEO) [Member] | Various Institutions [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Personal Guarantee Value (Benefit)                                           $ 758,000 $ 560
2018 Share Incentive Plan" (the "2018 Plan") [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Number of shares available for future grants | shares                           1,310,142                  
Weighted average fair value of each option grant                           $ 1.24 $ 4.7   $ 5.32            
Weighted average remaining contractual life for the share options outstanding                           1 year 9 months 10 days 3 years 9 months 3 days 3 years 9 months 3 days              
2018 Share Incentive Plan" (the "2018 Plan") [Member] | Vest on the first anniversary of the applicable vesting commencement date [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Awards vest                           33.30%                  
2018 Share Incentive Plan" (the "2018 Plan") [Member] | Vest in eight equal installments upon the lapse of each three-month period thereafter [Member]                                              
Disclosure of terms and conditions of share-based payment arrangement [line items]                                              
Awards vest                           66.70%